Home > Insider Trading > Filing (0000921895-19-002393)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
835887	Progenics Pharmaceuticals Inc	PGNX	Pharmaceutical Preparations (2834)	133379479

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1114916	Balaji Venkataraman	1055B Powers Place Alpharetta GA 30009	No	No	Yes	Yes
1772491	Altiva Management Inc.	1055B Powers Place Alpharetta GA 30009	No	No	Yes	Yes
1785731	Velan Capital, L.p.	1055 Powers Place, Suite B Alpharetta GA 30009	No	No	Yes	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0013 Par Value	Acquisiton	2019-09-09	72,023	$4.99	8,011,733	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4 is filed jointly by Velan Capital, L.P. ("Velan Capital"), Altiva Management Inc. ("Altiva"), and Balaji Venkataraman (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Securities owned directly by Velan Capital. Each of Altiva, as the general partner of Velan Capital, and Mr. Venkataraman, as the sole shareholder of Altiva, may be deemed to beneficially own the securities owned directly by Velan Capital.